Evidence map›Paper›PMID 40101192›Full record

ArticleACS synthetic biology2025

Preventing Multimer Formation in Commonly Used Synthetic Biology Plasmids.

Elizabeth Vaisbourd, Anat Bren, Uri Alon, David S Glass

Abstract read
In one paragraph

Article in ACS synthetic biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. High-resolution metagenome assembly for modern long reads with myloasm.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth VaisbourdDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 76100.
Anat BrenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 76100.
Uri AlonDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 76100.
David S GlassDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 76100.ORCID 0000-0001-8471-1763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmids are an essential tool for basic research and biotechnology applications. To optimize plasmid-based circuits, it is crucial to control plasmid integrity, including the formation of plasmid multimers. Multimers are tandem repeats of entire plasmids formed by failed dimer resolution during replication. Multimers can affect the behavior of synthetic circuits, especially ones that include DNA-editing enzymes. However, occurrence of multimers is not commonly assayed. Here we survey four commonly used plasmid backbones for occurrence of multimers in cloning (JM109) and wild-type (MG1655) strains of

Indexed as

PlasmidsSynthetic BiologyEscherichia coliconcatemerslong-read sequencingmultimersnanopore sequencingplasmidsrecombination

Identifiers

PMID40101192
PMCPMC12012879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.